Cheyenne Fenstemaker

Cheyenne Fenstemaker is a clinical research program manager in the Department of Social Medicine where she manages a multi-site NIH-funded implementation trial focused on expanding access to evidence-based treatment for opioid use disorder in rural primary care (MPIs: Franz and Miller). She works closely with Principal Investigator Dr. Berkeley Franz to coordinate trial operations, implementation activities, stakeholder engagement, and research across healthcare systems and community partners.

Cheyenne has published in peer-reviewed journals on rural health training and the implementation of buprenorphine in safety net and rural primary care settings.

Publications

Franz, Berkeley, Lindsay Y. Dhanani, Sean Bogart, Cheyenne Fenstemaker, William C. Miller, O. Trent Hall, Daniel Brook, and Vivian F. Go. “Different Forms of Stigma and Rural Primary Care Professionals’ Willingness to Prescribe Buprenorphine.” Journal of Substance Use and Addiction Treatment.

Fenstemaker, Cheyenne, Elizabeth Abrams, Katherine King, Benjamin Obringer, Daniel L. Brook, Vivian Go, William C. Miller, Lindsay Y. Dhanani, and Berkeley Franz. 2024. “The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.” Journal of General Internal Medicine. DOI: 10.1007/s11606-024-09260-1

Fenstemaker, Cheyenne, Benjamin Obringer, Elizabeth Abrams, Katherine King, Lindsay Y. Dhanani, and Berkeley Franz. 2023. “Primary Care Professionals’ Perspectives on Tailoring Buprenorphine Training for Rural Practice.” The Journal of rural health: official journal of the American Rural Health Association and the National Rural Health Care Association, 10.1111/jrh.12832.